G-CSF Infusion for Stem Cell Mobilization Transiently Increases Serum Cell-Free DNA and Protease Concentrations

Maria Stoikou1, Shane V van Breda1, Günther Schäfer1

  • 1Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.

Insights

Granulocyte-colony stimulating factor (G-CSF) mobilization does not prime neutrophils for extracellular trap (NET) formation. However, G-CSF increases factors in the blood that may promote thrombotic events under certain conditions.

Area of Science:

  • Hematology
  • Immunology
  • Thrombosis Research

Background:

  • Granulocyte-colony stimulating factor (G-CSF) is used for hematopoietic stem cell mobilization.
  • G-CSF increases circulating myeloid cells, including polymorphonuclear cells (PMNs).
  • Previous studies suggested G-CSF primes PMNs for neutrophil extracellular trap (NET) release, which is linked to thrombosis.

Purpose of the Study:

  • To investigate if G-CSF enhances PMN priming toward NET formation in healthy stem cell donors.
  • To determine the effect of high G-CSF concentrations on PMN activation and thrombotic potential.

Main Methods:

  • Analysis of circulating myeloid cell populations after G-CSF administration.
  • Assessment of PMN priming for NET formation.
  • Measurement of serum cell-free DNA, neutrophil elastase, myeloperoxidase, and reactive oxygen species.

Main Results:

  • G-CSF did not enhance PMN priming toward NET formation.
  • G-CSF significantly increased serum concentrations of cell-free DNA, neutrophil elastase, myeloperoxidase, and reactive oxygen species.
  • These changes indicate a pro-thrombotic environment may be created.

Conclusions:

  • G-CSF does not directly prime PMNs for NET formation.
  • Elevated levels of specific molecules due to G-CSF may contribute to thrombotic events.
  • Further research is needed to understand the thrombotic risk associated with G-CSF therapy.